Rare diseases
Investigational molecules
Locations
Av. de la República Argentina, S/N, 08940 Cornellà de Llobregat, Spain
The medical center is at the forefront of migraine management, focusing on the comparative effectiveness of preventive treatments in primary care settings. This research aims to enhance patient outcomes by identifying the most effective first-line medications.
By investigating the efficacy of medications such as amitriptyline, flunarizine, topiramate, and propranolol, the center contributes significantly to the optimization of migraine treatment protocols, ensuring that patients receive the most effective care tailored to their needs.
More sites in Cornellà de LlobregatSpain
Clinical trials currently enrolling participants at this site.
SpainGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
